Weiguo Zhu Shi Tao Wenchun Miao Hui Liu Xianggui Yuan
10.3389/fimmu.2022.894787
Front Immunol
2022 Jun 10;13:894787.
bruton’s tyrosine kinase inhibitor chidamide chimeric antigen receptor t cell diffuse large b-cell lymphoma histone deacetylase inhibitor zanubrutinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/35757723/
Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Receptors, Chimeric Antigen
Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Receptors, Chimeric Antigen Case Reports Research Support, Non-U.S. Gov't Aged Antigens, CD19 Humans Immunotherapy, Adoptive / adverse effects T-Lymphocytes Antigens, CD19 Receptors, Chimeric Antigen
PMC9226330
35757723
Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy
2022